glp 1 cause gastritis Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus Mapping the effectiveness and risks

Patient education : Patients need support as they work to understand their medical, dietary, and lifestyle choices

December 2025: Growing integration of GLP-1 therapies in Japan's diabetes clinics and hospitals, driven by increasing obesity-related comorbidities and demand for convenient administration routes

The researchers focused only on patients with type 2 diabetes because their prescriptions were tracked through 2018, when GLP-1 drugs were still approved only for diabetes, explained Lindsey Wang, the lead author and a sophomore at Case Western Reserve University who has been studying under the senior author, the late Nathan Berger, for the past five years

Metformin, a first-line T2DM treatment, affects the gastrointestinal tract by altering glucose uptake, GLP-1 secretion, gut microbiota, and immune response [33, 34], but it rarely causes bowel obstruction